Domain Therapeutics is based in Strasbourg, France. It has raised $53M in total funding. Latest round: Series A.
Domain Therapeutics is based in Strasbourg, France. Domain Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2022. The round record for Domain Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Panacea Venture, CTI Life Sciences, 3B Future Health Fund, adMare BioInnovations, Schroders Capital, Omnes and 4 others. 10 distinct backers are named across the disclosed rounds.
Round data for Domain Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Strasbourg and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026